Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T81183 | ||||
Target Name | Adrenergic receptor Alpha-1 (ADRA1) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Carvedilol | Drug Info | Ki = 0.4 nM | [2] | |
Prazosin | Drug Info | pKi = 6.11 | [1] | ||
Tamsulosin | Drug Info | pKi = 9.13 | [4] | ||
Action against Disease Model | Tamsulosin | Drug Info | IC50 on tension responses to electrical field stimulation (0.3 ms duration, 80 V and 20 Hz) in h uMan hyperplastic prostate: 0.193nM | [3] | |
References | |||||
REF 1 | Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes. Curr Top Med Chem. 2007;7(2):163-86. | ||||
REF 2 | Recent advances in identification and characterization of beta-adrenoceptor agonists and antagonists. Curr Top Med Chem. 2007;7(2):207-16. | ||||
REF 3 | Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation. Eur J Pharmacol. 1996 Jun 3;305(1-3):177-80. | ||||
REF 4 | Tamsulosin: assessment of affinity of 3H-prazosin bindings to two alpha1-adrenoceptor subtypes (alpha1H and alpha1L) in bovine prostate and rat heart and brain. Gen Pharmacol. 1998 Oct;31(4):597-600. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.